| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CLO, Interim CFO, Corp Sec. | Chief Legal Officer, Corp Sec.
1 company
Lim Bryant David is a CLO, Interim CFO, Corp Sec. at Prelude Therapeutics Inc. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $141K based on current market prices.